Alexandria Real Estate Equities
ARE
#2319
Rank
$7.86 B
Marketcap
$45.48
Share price
-2.38%
Change (1 day)
-54.16%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Alexandria Real Estate Equities (ARE) - Net assets

Net assets on the balance sheet as of September 2025 : $21.11 Billion USD

According to Alexandria Real Estate Equities 's latest financial reports the company has $21.11 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alexandria Real Estate Equities - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$$22.39 B-0.99%
2023-12-31$$22.62 B-0.27%
2022-12-31$$22.68 B19.18%
2021-12-31$$19.03 B41.58%
2020-12-31$$13.44 B32.24%
2019-12-31$$10.16 B28.78%
2018-12-31$$7.89 B21.77%
2017-12-31$$6.48 B20.45%
2016-12-31$$5.38 B25.35%
2015-12-31$$4.29 B9.83%
2014-12-31$$3.90 B-1.74%
2013-12-31$$3.97 B13.58%
2012-12-31$$3.50 B2.04%
2011-12-31$$3.43 B14.95%
2010-12-31$$2.98 B24.12%
2009-12-31$$2.40 B38.19%
2008-12-31$$1.74 B15.78%
2007-12-31$$1.50 B6.72%
2006-12-31$$1.40 B65.8%
2005-12-31$$0.84 B36.98%
2004-12-31$$0.62 B22.35%
2003-12-31$$0.50 B4.38%
2002-12-31$$0.48 B46.06%
2001-12-31$$0.33 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
$93.09 B 340.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$21.45 B 1.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$23.85 B 12.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$2.38 B-88.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$18.60 B-11.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$9.61 B-54.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$0.23 B-98.89%๐Ÿ‡บ๐Ÿ‡ธ USA